FDA Mandates Breast Density Notification for All Mammogram Patients

New rule ensures women are informed about breast density risks and encourages discussions on additional screenings.

Effective September 10, 2024, mammogram facilities must notify women about their breast density.
Dense breast tissue can obscure cancer on mammograms and increase cancer risk.
3D mammograms and supplemental screenings such as ultrasounds and MRIs may aid in cancer detection.
Insurance coverage for supplemental screenings remains inconsistent across states.
Effective patient-doctor communication is crucial to navigate breast cancer screening options.